BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet 2007;369:499-511. [PMID: 17292770 DOI: 10.1016/S0140-6736(07)60237-2] [Cited by in Crossref: 471] [Cited by in F6Publishing: 147] [Article Influence: 31.4] [Reference Citation Analysis]
Number Citing Articles
1 Iranzo A, Serralheiro P, Schuller JC, Schlit AF, Bentz JWG. Evaluation of the Effectiveness of the Risk Minimization Measures of Sodium Oxybate in the European Union. Drugs Real World Outcomes 2020;7:307-15. [PMID: 32989679 DOI: 10.1007/s40801-020-00212-9] [Reference Citation Analysis]
2 Abid M, Kietzerow J, Iwersen-Bergmann S, Schnitgerhans T, Andresen-Streichert H. Characteristics and dose-effect relationship of clinical gamma-hydroxybutyrate intoxication: A case series. J Forensic Sci 2021. [PMID: 34523720 DOI: 10.1111/1556-4029.14880] [Reference Citation Analysis]
3 van Holst RJ, van der Cruijsen L, van Mierlo P, Lammers GJ, Cools R, Overeem S, Aarts E. Aberrant Food Choices after Satiation in Human Orexin-Deficient Narcolepsy Type 1. Sleep 2016;39:1951-9. [PMID: 27568806 DOI: 10.5665/sleep.6222] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
4 Nishino S, Okuro M, Kotorii N, Anegawa E, Ishimaru Y, Matsumura M, Kanbayashi T. Hypocretin/orexin and narcolepsy: new basic and clinical insights. Acta Physiol (Oxf) 2010;198:209-22. [PMID: 19555382 DOI: 10.1111/j.1748-1716.2009.02012.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
5 Flores NM, Villa KF, Black J, Chervin RD, Witt EA. The Humanistic and Economic Burden of Narcolepsy. J Clin Sleep Med 2016;12:401-7. [PMID: 26518705 DOI: 10.5664/jcsm.5594] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
6 Stettner GM, Kubin L. Antagonism of orexin receptors in the posterior hypothalamus reduces hypoglossal and cardiorespiratory excitation from the perifornical hypothalamus. J Appl Physiol (1985) 2013;114:119-30. [PMID: 23104701 DOI: 10.1152/japplphysiol.00965.2012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
7 Uzun N, Akıncı MA. Treatment of Isolated Cataplexy With Low-dose Aripiprazole in an Adolescent Patient. Clin Neuropharmacol 2020;43:125-6. [PMID: 32590615 DOI: 10.1097/WNF.0000000000000398] [Reference Citation Analysis]
8 Mansukhani MP, Covassin N, Somers VK. Neurological Sleep Disorders and Blood Pressure: Current Evidence. Hypertension 2019;74:726-32. [PMID: 31476906 DOI: 10.1161/HYPERTENSIONAHA.119.13456] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Geng C, Yang Z, Xu P, Zhang H. Psychological status and serum uric acid levels in narcolepsy with type 1: A case-control study. J Clin Neurosci 2022;97:17-20. [PMID: 35033776 DOI: 10.1016/j.jocn.2022.01.002] [Reference Citation Analysis]
10 van der Heide A, Werth E, Donjacour CE, Reijntjes RH, Lammers GJ, Van Someren EJ, Baumann CR, Fronczek R. Core Body and Skin Temperature in Type 1 Narcolepsy in Daily Life; Effects of Sodium Oxybate and Prediction of Sleep Attacks. Sleep 2016;39:1941-9. [PMID: 27568803 DOI: 10.5665/sleep.6220] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Koepsell TD, Longstreth WT, Ton TG. Medical exposures in youth and the frequency of narcolepsy with cataplexy: a population-based case-control study in genetically predisposed people. J Sleep Res 2010;19:80-6. [PMID: 19732319 DOI: 10.1111/j.1365-2869.2009.00756.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 4.1] [Reference Citation Analysis]
12 de Sá JF, Mota-Rolim SA. Sleep Paralysis in Brazilian Folklore and Other Cultures: A Brief Review. Front Psychol 2016;7:1294. [PMID: 27656151 DOI: 10.3389/fpsyg.2016.01294] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Guo RX, Anaclet C, Roberts JC, Parmentier R, Zhang M, Guidon G, Buda C, Sastre JP, Feng JQ, Franco P, Brown SH, Upton N, Medhurst AD, Lin JS. Differential effects of acute and repeat dosing with the H3 antagonist GSK189254 on the sleep-wake cycle and narcoleptic episodes in Ox-/- mice. Br J Pharmacol 2009;157:104-17. [PMID: 19413575 DOI: 10.1111/j.1476-5381.2009.00205.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
14 Lopes DA, Coelho FM, Pradella-Hallinan M, de Araújo Melo MH, Tufik S. Infancy narcolepsy: Streptococcus infection as a causal factor. Sleep Sci 2015;8:49-52. [PMID: 26483943 DOI: 10.1016/j.slsci.2015.02.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 Dauvilliers Y, Gaig C, Barateau L, Graus F, Iranzo A, Lopez R, Santamaria J. Absence of NMDA receptor antibodies in the rare association between Type 1 Narcolepsy and Psychosis. Sci Rep 2016;6:25230. [PMID: 27143278 DOI: 10.1038/srep25230] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
16 Wozniak DR, Quinnell TG. Unmet needs of patients with narcolepsy: perspectives on emerging treatment options. Nat Sci Sleep 2015;7:51-61. [PMID: 26045680 DOI: 10.2147/NSS.S56077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
17 Barateau L, Jaussent I, Lopez R, Evangelista E, Chenini S, Benkiran M, Mariano-Goulart D, Dauvilliers Y. Cardiac Sympathetic Activity differentiates Idiopathic and Symptomatic Rapid Eye Movement Sleep Behaviour Disorder. Sci Rep 2018;8:7304. [PMID: 29740055 DOI: 10.1038/s41598-018-25547-w] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
18 Dauvilliers Y, Montplaisir J, Cochen V, Desautels A, Einen M, Lin L, Kawashima M, Bayard S, Monaca C, Tiberge M, Filipini D, Tripathy A, Nguyen BH, Kotagal S, Mignot E. Post-H1N1 narcolepsy-cataplexy. Sleep 2010;33:1428-30. [PMID: 21102981 DOI: 10.1093/sleep/33.11.1428] [Cited by in Crossref: 150] [Cited by in F6Publishing: 115] [Article Influence: 13.6] [Reference Citation Analysis]
19 Szakács A, Hallböök T, Tideman P, Darin N, Wentz E. Psychiatric comorbidity and cognitive profile in children with narcolepsy with or without association to the H1N1 influenza vaccination. Sleep 2015;38:615-21. [PMID: 25325473 DOI: 10.5665/sleep.4582] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.9] [Reference Citation Analysis]
20 Roth T, Dauvilliers Y, Mignot E, Montplaisir J, Paul J, Swick T, Zee P. Disrupted nighttime sleep in narcolepsy. J Clin Sleep Med 2013;9:955-65. [PMID: 23997709 DOI: 10.5664/jcsm.3004] [Cited by in Crossref: 96] [Cited by in F6Publishing: 85] [Article Influence: 12.0] [Reference Citation Analysis]
21 Dauvilliers Y, Delallée N, Jaussent I, Scholz S, Bayard S, Croyal M, Schwartz JC, Robert P. Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions. Sleep 2012;35:1359-66. [PMID: 23024434 DOI: 10.5665/sleep.2114] [Cited by in Crossref: 64] [Cited by in F6Publishing: 49] [Article Influence: 6.4] [Reference Citation Analysis]
22 Li S, Franken P, Vassalli A. Bidirectional and context-dependent changes in theta and gamma oscillatory brain activity in noradrenergic cell-specific Hypocretin/Orexin receptor 1-KO mice. Sci Rep 2018;8:15474. [PMID: 30341359 DOI: 10.1038/s41598-018-33069-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
23 Holm A, Bang-Berthelsen CH, Knudsen S, Kornum BR, Modvig S, Jennum P, Gammeltoft S. miRNA profiles in plasma from patients with sleep disorders reveal dysregulation of miRNAs in narcolepsy and other central hypersomnias. Sleep 2014;37:1525-33. [PMID: 25142559 DOI: 10.5665/sleep.4004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
24 Harwell V, Fasinu PS. Pitolisant and Other Histamine-3 Receptor Antagonists-An Update on Therapeutic Potentials and Clinical Prospects. Medicines (Basel) 2020;7:E55. [PMID: 32882898 DOI: 10.3390/medicines7090055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
25 Hoyer D, Jacobson LH. Orexin Receptor Antagonists. Curr Sleep Medicine Rep 2017;3:342-53. [DOI: 10.1007/s40675-017-0099-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
26 Busardò FP, Jones AW. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome. Curr Neuropharmacol 2015;13:47-70. [PMID: 26074743 DOI: 10.2174/1570159X13666141210215423] [Cited by in Crossref: 99] [Cited by in F6Publishing: 24] [Article Influence: 16.5] [Reference Citation Analysis]
27 Ferguson D, Wrigley S, Purcell E, Keane S, McGinn B, O'Malley S, Lynch B, Crowe C. Single center analysis of patients with H1N1 vaccine-related narcolepsy and sporadic narcolepsy presenting over the same time period. J Clin Sleep Med 2021;17:885-95. [PMID: 33289477 DOI: 10.5664/jcsm.9052] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Lilienfeld SO, Pydych AL, Lynn SJ, Latzman RD, Waldman ID. 50 Differences That Make a Difference: A Compendium of Frequently Confused Term Pairs in Psychology. Front Educ 2017;2:37. [DOI: 10.3389/feduc.2017.00037] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
29 Sonka K, Susta M. Diagnosis and management of central hypersomnias. Ther Adv Neurol Disord 2012;5:297-305. [PMID: 22973425 DOI: 10.1177/1756285612454692] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
30 Chen MC, Yu H, Huang ZL, Lu J. Rapid eye movement sleep behavior disorder. Curr Opin Neurobiol 2013;23:793-8. [PMID: 23518139 DOI: 10.1016/j.conb.2013.02.019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
31 Almeneessier AS, Al-Jebrin S, Labani R, Alkaff H, Al-Rahbeeni O, Alageel M, Olaish A, BaHammam AS. Medical specialty visits and diagnoses received by Saudi patients prior to a diagnosis of narcolepsy. Sleep Breath 2019;23:603-9. [PMID: 30820852 DOI: 10.1007/s11325-019-01807-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
32 Leclair-visonneau L. Orientation diagnostique devant une plainte d’hypersomnolence. La Revue de Médecine Interne 2022. [DOI: 10.1016/j.revmed.2022.01.004] [Reference Citation Analysis]
33 Bergman P, Adori C, Vas S, Kai-Larsen Y, Sarkanen T, Cederlund A, Agerberth B, Julkunen I, Horvath B, Kostyalik D, Kalmár L, Bagdy G, Huutoniemi A, Partinen M, Hökfelt T. Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns. Proc Natl Acad Sci U S A 2014;111:E3735-44. [PMID: 25136085 DOI: 10.1073/pnas.1412189111] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 7.4] [Reference Citation Analysis]
34 Snow MB, Fraigne JJ, Thibault-Messier G, Chuen VL, Thomasian A, Horner RL, Peever J. GABA Cells in the Central Nucleus of the Amygdala Promote Cataplexy. J Neurosci 2017;37:4007-22. [PMID: 28209737 DOI: 10.1523/JNEUROSCI.4070-15.2017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 4.6] [Reference Citation Analysis]
35 Dauvilliers Y, Arnulf I. Narcolepsie avec cataplexie. Revue Neurologique 2008;164:634-45. [DOI: 10.1016/j.neurol.2007.08.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
36 Zhu J, Zeng Z, Xiong M, Mo H, Jin M, Hu K. Associations between daytime and nighttime plasma orexin A levels and cognitive function in patients with obstructive sleep apnea. Sleep Biol Rhythms. [DOI: 10.1007/s41105-022-00387-4] [Reference Citation Analysis]
37 Hanin C, Arnulf I, Maranci JB, Lecendreux M, Levinson DF, Cohen D, Laurent-Levinson C. Narcolepsy and psychosis: A systematic review. Acta Psychiatr Scand 2021;144:28-41. [PMID: 33779983 DOI: 10.1111/acps.13300] [Reference Citation Analysis]
38 Barateau L, Dauvilliers Y. Recent advances in treatment for narcolepsy. Ther Adv Neurol Disord 2019;12:1756286419875622. [PMID: 31632459 DOI: 10.1177/1756286419875622] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 7.7] [Reference Citation Analysis]
39 Peyron C, Seugnet L, Lin JS. Commentary: A Quest for a Novel Peripheral Biomarker for Narcolepsy. CNS Neurosci Ther 2015;21:681-2. [PMID: 26281778 DOI: 10.1111/cns.12433] [Reference Citation Analysis]
40 Seifinejad A, Vassalli A, Tafti M. Neurobiology of cataplexy. Sleep Med Rev 2021;60:101546. [PMID: 34607185 DOI: 10.1016/j.smrv.2021.101546] [Reference Citation Analysis]
41 Hasegawa E, Yanagisawa M, Sakurai T, Mieda M. Orexin neurons suppress narcolepsy via 2 distinct efferent pathways. J Clin Invest 2014;124:604-16. [PMID: 24382351 DOI: 10.1172/JCI71017] [Cited by in Crossref: 96] [Cited by in F6Publishing: 49] [Article Influence: 12.0] [Reference Citation Analysis]
42 Couvineau A, Voisin T, Nicole P, Gratio V, Abad C, Tan YV. Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases. Front Endocrinol (Lausanne) 2019;10:709. [PMID: 31695678 DOI: 10.3389/fendo.2019.00709] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
43 Dodet P, Chavez M, Leu-Semenescu S, Golmard JL, Arnulf I. Lucid dreaming in narcolepsy. Sleep 2015;38:487-97. [PMID: 25348131 DOI: 10.5665/sleep.4516] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
44 Joiner WJ. Unraveling the Evolutionary Determinants of Sleep. Curr Biol 2016;26:R1073-87. [PMID: 27780049 DOI: 10.1016/j.cub.2016.08.068] [Cited by in Crossref: 94] [Cited by in F6Publishing: 63] [Article Influence: 18.8] [Reference Citation Analysis]
45 Lopez R, Micoulaud-Franchi JA, Camodeca L, Gachet M, Jaussent I, Dauvilliers Y. Association of Inattention, Hyperactivity, and Hypersomnolence in Two Clinic-Based Adult Cohorts. J Atten Disord 2020;24:555-64. [PMID: 29771183 DOI: 10.1177/1087054718775826] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
46 Caputo F, Vignoli T, Maremmani I, Bernardi M, Zoli G. Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: a review. Int J Environ Res Public Health 2009;6:1917-29. [PMID: 19578468 DOI: 10.3390/ijerph6061917] [Cited by in Crossref: 50] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
47 Baek JH, Jeon J, Lee S. Narcolepsy Patient Presenting as Drop Attack without Emotional Triggering and Subjective Sleepiness. Sleep Med Res 2016;7:74-7. [DOI: 10.17241/smr.2016.00094] [Reference Citation Analysis]
48 Bayard S, Dauvilliers YA. Reward-based behaviors and emotional processing in human with narcolepsy-cataplexy. Front Behav Neurosci 2013;7:50. [PMID: 23734110 DOI: 10.3389/fnbeh.2013.00050] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
49 Khan Z, Trotti LM. Central Disorders of Hypersomnolence: Focus on the Narcolepsies and Idiopathic Hypersomnia. Chest 2015;148:262-73. [PMID: 26149554 DOI: 10.1378/chest.14-1304] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 5.4] [Reference Citation Analysis]
50 Ouyang H, Han F, Zhou ZC, Zheng QW, Wang YY, Zhang J. Relationship between T-cell receptor α gene polymorphisms and symptomatic differences in patients with narcolepsy type 1. Chin Med J (Engl) 2019;132:1796-801. [PMID: 31343434 DOI: 10.1097/CM9.0000000000000348] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Bayard S, Langenier MC, Dauvilliers Y. Effect of psychostimulants on impulsivity and risk taking in narcolepsy with cataplexy. Sleep 2013;36:1335-40. [PMID: 23997366 DOI: 10.5665/sleep.2958] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
52 Ouyang H, Han F, Zheng Q, Zhang J. Chinese version of narcolepsy severity scale: a validation study. BMC Neurol 2019;19:334. [PMID: 31864300 DOI: 10.1186/s12883-019-1570-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
53 Bernard-Valnet R, Yshii L, Quériault C, Nguyen XH, Arthaud S, Rodrigues M, Canivet A, Morel AL, Matthys A, Bauer J, Pignolet B, Dauvilliers Y, Peyron C, Liblau RS. CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice. Proc Natl Acad Sci U S A 2016;113:10956-61. [PMID: 27621438 DOI: 10.1073/pnas.1603325113] [Cited by in Crossref: 73] [Cited by in F6Publishing: 62] [Article Influence: 12.2] [Reference Citation Analysis]
54 . [Hypocretin neurotransmitter system and narcolepsy]. Vojnosanit Pregl 2008;65:393-6. [PMID: 18630134 DOI: 10.2298/vsp0805393l] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
55 Mochizuki T, Arrigoni E, Marcus JN, Clark EL, Yamamoto M, Honer M, Borroni E, Lowell BB, Elmquist JK, Scammell TE. Orexin receptor 2 expression in the posterior hypothalamus rescues sleepiness in narcoleptic mice. Proc Natl Acad Sci U S A 2011;108:4471-6. [PMID: 21368172 DOI: 10.1073/pnas.1012456108] [Cited by in Crossref: 85] [Cited by in F6Publishing: 90] [Article Influence: 7.7] [Reference Citation Analysis]
56 Nakamura M, Nishida S, Hayashida K, Ueki Y, Dauvilliers Y, Inoue Y. Differences in brain morphological findings between narcolepsy with and without cataplexy. PLoS One 2013;8:e81059. [PMID: 24312261 DOI: 10.1371/journal.pone.0081059] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
57 Liblau RS. Put to sleep by immune cells. Nature 2018;562:46-8. [PMID: 30275550 DOI: 10.1038/d41586-018-06666-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
58 Nirogi R, Shinde A, Mohammed AR, Badange RK, Reballi V, Bandyala TR, Saraf SK, Bojja K, Manchineella S, Achanta PK, Kandukuri KK, Subramanian R, Benade V, Palacharla RC, Jayarajan P, Pandey S, Jasti V. Discovery and Development of N-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide Dihydrochloride (SUVN-G3031): A Novel, Potent, Selective, and Orally Active Histamine H3 Receptor Inverse Agonist with Robust Wake-Promoting Activity. J Med Chem 2019;62:1203-17. [PMID: 30629436 DOI: 10.1021/acs.jmedchem.8b01280] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
59 Dang-Vu TT. Neuroimaging findings in narcolepsy with cataplexy. Curr Neurol Neurosci Rep 2013;13:349. [PMID: 23526549 DOI: 10.1007/s11910-013-0349-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
60 Ouyang H, Gao X, Zhang J. Symptom measures in pediatric narcolepsy patients: a review. Ital J Pediatr 2021;47:124. [PMID: 34078436 DOI: 10.1186/s13052-021-01068-7] [Reference Citation Analysis]
61 Maresova P, Novotny M, Klímová B, Kuča K. Treatment cost of narcolepsy with cataplexy in Central Europe. Ther Clin Risk Manag 2016;12:1709-15. [PMID: 27920540 DOI: 10.2147/TCRM.S119888] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
62 Wang X. Narcolepsy induced by chronic heavy alcohol consumption: a case report. Shanghai Arch Psychiatry 2012;24:294-6. [PMID: 25328357 DOI: 10.3969/j.issn.1002-0829.2012.05.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
63 Schwartz JC. The histamine H3 receptor: from discovery to clinical trials with pitolisant. Br J Pharmacol 2011;163:713-21. [PMID: 21615387 DOI: 10.1111/j.1476-5381.2011.01286.x] [Cited by in Crossref: 192] [Cited by in F6Publishing: 170] [Article Influence: 17.5] [Reference Citation Analysis]
64 Pedersen NW, Holm A, Kristensen NP, Bjerregaard AM, Bentzen AK, Marquard AM, Tamhane T, Burgdorf KS, Ullum H, Jennum P, Knudsen S, Hadrup SR, Kornum BR. CD8+ T cells from patients with narcolepsy and healthy controls recognize hypocretin neuron-specific antigens. Nat Commun 2019;10:837. [PMID: 30783092 DOI: 10.1038/s41467-019-08774-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 14.3] [Reference Citation Analysis]
65 Plazzi G, Pizza F. Sleep dynamics beyond traditional sleep macrostructure. Sleep 2013;36:1123-4. [PMID: 23904669 DOI: 10.5665/sleep.2864] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
66 Plazzi G, Tinuper P. Praxis-induced seizures misdiagnosed as cataplexy: a case report. Mov Disord 2008;23:2105-7. [PMID: 18709676 DOI: 10.1002/mds.22252] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
67 Lee EK, Douglass AB. Baclofen for narcolepsy with cataplexy: two cases. Nat Sci Sleep 2015;7:81-3. [PMID: 26251634 DOI: 10.2147/NSS.S86649] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
68 Bridoux A, Moutereau S, Covali-Noroc A, Margarit L, Palfi S, Nguyen JP, Lefaucheur JP, Césaro P, d'Ortho MP, Drouot X. Ventricular orexin-A (hypocretin-1) levels correlate with rapid-eye-movement sleep without atonia in Parkinson's disease. Nat Sci Sleep 2013;5:87-91. [PMID: 23847436 DOI: 10.2147/NSS.S41245] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
69 Bernardini C, Lattanzi W, Bosco P, Franceschini C, Plazzi G, Michetti F, Ferri R. Genome-wide gene expression profiling of human narcolepsy. Gene Expr 2012;15:171-81. [PMID: 22783726 DOI: 10.3727/105221612x13372578119652] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
70 Garcia-Sicilia J, Arístegui J, Omeñaca F, Carmona A, Tejedor JC, Merino JM, García-Corbeira P, Walravens K, Bambure V, Moris P, Caplanusi A, Gillard P, Dieussaert I. Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, children and adolescents: Two open, uncontrolled studies. Hum Vaccin Immunother 2015;11:2359-69. [PMID: 26176592 DOI: 10.1080/21645515.2015.1063754] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
71 Natori Y, Sasaki E, Soeda S, Furukawa S, Azami Y, Tokuda E, Kanbayashi T, Saji S. Risk of immunotherapy-related narcolepsy in genetically predisposed patients: a case report of narcolepsy after administration of pembrolizumab. J Immunother Cancer 2020;8:e001164. [PMID: 33004543 DOI: 10.1136/jitc-2020-001164] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
72 Chen YH, Huang YS, Chen CH. Increased plasma level of tumor necrosis factor α in patients with narcolepsy in Taiwan. Sleep Med 2013;14:1272-6. [PMID: 24157100 DOI: 10.1016/j.sleep.2013.04.030] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
73 Dauvilliers Y, Evangelista E, de Verbizier D, Barateau L, Peigneux P. [18F]Fludeoxyglucose-Positron Emission Tomography Evidence for Cerebral Hypermetabolism in the Awake State in Narcolepsy and Idiopathic Hypersomnia. Front Neurol 2017;8:350. [PMID: 28775709 DOI: 10.3389/fneur.2017.00350] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
74 Barateau L, Chenini S, Lotierzo M, Rassu AL, Evangelista E, Lopez R, Gorce Dupuy AM, Jaussent I, Dauvilliers Y. CSF and serum ferritin levels in narcolepsy type 1 comorbid with restless legs syndrome. Ann Clin Transl Neurol 2020;7:924-31. [PMID: 32432412 DOI: 10.1002/acn3.51056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
75 Beable A. Transient paralysis during acupuncture therapy: a case report of an adverse event. Acupunct Med 2013;31:319-24. [PMID: 23660010 DOI: 10.1136/acupmed-2013-010374] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
76 Drissi NM, Szakács A, Witt ST, Wretman A, Ulander M, Ståhlbrandt H, Darin N, Hallböök T, Landtblom AM, Engström M. Altered Brain Microstate Dynamics in Adolescents with Narcolepsy. Front Hum Neurosci 2016;10:369. [PMID: 27536225 DOI: 10.3389/fnhum.2016.00369] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
77 Cvetkovic-Lopes V, Bayer L, Dorsaz S, Maret S, Pradervand S, Dauvilliers Y, Lecendreux M, Lammers GJ, Donjacour CE, Du Pasquier RA, Pfister C, Petit B, Hor H, Mühlethaler M, Tafti M. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J Clin Invest 2010;120:713-9. [PMID: 20160349 DOI: 10.1172/JCI41366] [Cited by in Crossref: 215] [Cited by in F6Publishing: 77] [Article Influence: 17.9] [Reference Citation Analysis]
78 Barateau L, Lopez R, Dauvilliers Y. Clinical neurophysiology of CNS hypersomnias. Handb Clin Neurol 2019;161:353-67. [PMID: 31307613 DOI: 10.1016/B978-0-444-64142-7.00060-6] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
79 Dauvilliers Y, Pennestri MH, Whittom S, Lanfranchi PA, Montplaisir JY. Autonomic response to periodic leg movements during sleep in narcolepsy-cataplexy. Sleep 2011;34:219-23. [PMID: 21286243 DOI: 10.1093/sleep/34.2.219] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
80 Dauvilliers Y, Jaussent I, Krams B, Scholz S, Lado S, Levy P, Pepin JL. Non-dipping blood pressure profile in narcolepsy with cataplexy. PLoS One 2012;7:e38977. [PMID: 22768053 DOI: 10.1371/journal.pone.0038977] [Cited by in Crossref: 61] [Cited by in F6Publishing: 50] [Article Influence: 6.1] [Reference Citation Analysis]
81 Dondé C, Polosan M, Guzun R. Pitolisant for Treating Narcolepsy Comorbid With Schizophrenia. J Clin Psychopharmacol 2020;40:504-6. [DOI: 10.1097/jcp.0000000000001243] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Tesoriero C, Codita A, Zhang MD, Cherninsky A, Karlsson H, Grassi-Zucconi G, Bertini G, Harkany T, Ljungberg K, Liljeström P, Hökfelt TG, Bentivoglio M, Kristensson K. H1N1 influenza virus induces narcolepsy-like sleep disruption and targets sleep-wake regulatory neurons in mice. Proc Natl Acad Sci U S A 2016;113:E368-77. [PMID: 26668381 DOI: 10.1073/pnas.1521463112] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 7.4] [Reference Citation Analysis]
83 Heidbreder A, Dirks C, Ramm M. Therapy for Cataplexy. Curr Treat Options Neurol 2020;22. [DOI: 10.1007/s11940-020-0619-5] [Reference Citation Analysis]
84 Dauvilliers Y, Lopez R, Ohayon M, Bayard S. Hypersomnia and depressive symptoms: methodological and clinical aspects. BMC Med 2013;11:78. [PMID: 23514569 DOI: 10.1186/1741-7015-11-78] [Cited by in Crossref: 72] [Cited by in F6Publishing: 57] [Article Influence: 8.0] [Reference Citation Analysis]
85 Dauvilliers Y, Bogan RK, Šonka K, Partinen M, Foldvary-schaefer N, Thorpy MJ. Calcium, Magnesium, Potassium, and Sodium Oxybates Oral Solution: A Lower-Sodium Alternative for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy. NSS 2022;Volume 14:531-46. [DOI: 10.2147/nss.s279345] [Reference Citation Analysis]
86 Tan NC, Fisher WG, Rosenblatt KP, Garner HR. Application of multiple statistical tests to enhance mass spectrometry-based biomarker discovery. BMC Bioinformatics 2009;10:144. [PMID: 19442303 DOI: 10.1186/1471-2105-10-144] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
87 Caporali L, Moresco M, Pizza F, La Morgia C, Fiorini C, Strobbe D, Zenesini C, Hooshiar Kashani B, Torroni A, Pagotto U, Carelli V, Plazzi G. The role of mtDNA haplogroups on metabolic features in narcolepsy type 1. Mitochondrion 2022:S1567-7249(22)00005-8. [PMID: 35051655 DOI: 10.1016/j.mito.2022.01.005] [Reference Citation Analysis]
88 Barateau L, Pizza F, Lopez R, Antelmi E, Plazzi G, Dauvilliers Y. Persistence of deep-tendon reflexes during partial cataplexy. Sleep Medicine 2018;45:80-2. [DOI: 10.1016/j.sleep.2017.12.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
89 Hor H, Bartesaghi L, Kutalik Z, Vicário JL, de Andrés C, Pfister C, Lammers GJ, Guex N, Chrast R, Tafti M, Peraita-Adrados R. A missense mutation in myelin oligodendrocyte glycoprotein as a cause of familial narcolepsy with cataplexy. Am J Hum Genet 2011;89:474-9. [PMID: 21907016 DOI: 10.1016/j.ajhg.2011.08.007] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
90 Dallé E, Mabandla MV. Early Life Stress, Depression And Parkinson's Disease: A New Approach. Mol Brain 2018;11:18. [PMID: 29551090 DOI: 10.1186/s13041-018-0356-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 9.3] [Reference Citation Analysis]
91 Branch AF, Navidi W, Tabuchi S, Terao A, Yamanaka A, Scammell TE, Diniz Behn C. Progressive Loss of the Orexin Neurons Reveals Dual Effects on Wakefulness. Sleep 2016;39:369-77. [PMID: 26446125 DOI: 10.5665/sleep.5446] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
92 Hirtz C, Vialaret J, Gabelle A, Nowak N, Dauvilliers Y, Lehmann S. From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid. Sci Rep 2016;6:25162. [PMID: 27165941 DOI: 10.1038/srep25162] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
93 Pizza F, Jaussent I, Lopez R, Pesenti C, Plazzi G, Drouot X, Leu-Semenescu S, Beziat S, Arnulf I, Dauvilliers Y. Car Crashes and Central Disorders of Hypersomnolence: A French Study. PLoS One 2015;10:e0129386. [PMID: 26052938 DOI: 10.1371/journal.pone.0129386] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
94 Drakatos P, Lykouras D, D'Ancona G, Higgins S, Gildeh N, Macavei R, Rosenzweig I, Steier J, Williams AJ, Muza R, Kent BD, Leschziner G. Safety and efficacy of long-term use of sodium oxybate for narcolepsy with cataplexy in routine clinical practice. Sleep Med 2017;35:80-4. [PMID: 28619187 DOI: 10.1016/j.sleep.2017.03.028] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
95 Flygare J, Parthasarathy S. Narcolepsy: let the patient's voice awaken us! Am J Med 2015;128:10-3. [PMID: 24931392 DOI: 10.1016/j.amjmed.2014.05.037] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
96 Yang Y, Li C, Zhao L, Li J, Han F, Xiao F. Factors Associated with Depression and Sub-Dimension Symptoms in Adolescent Narcolepsy. Nat Sci Sleep 2021;13:1075-82. [PMID: 34262378 DOI: 10.2147/NSS.S312000] [Reference Citation Analysis]
97 Apergis-Schoute J, Iordanidou P, Faure C, Jego S, Schöne C, Aitta-Aho T, Adamantidis A, Burdakov D. Optogenetic evidence for inhibitory signaling from orexin to MCH neurons via local microcircuits. J Neurosci 2015;35:5435-41. [PMID: 25855162 DOI: 10.1523/JNEUROSCI.5269-14.2015] [Cited by in Crossref: 79] [Cited by in F6Publishing: 52] [Article Influence: 11.3] [Reference Citation Analysis]
98 Schwartz JR, Roth T. Neurophysiology of sleep and wakefulness: basic science and clinical implications. Curr Neuropharmacol 2008;6:367-78. [PMID: 19587857 DOI: 10.2174/157015908787386050] [Cited by in Crossref: 150] [Cited by in F6Publishing: 123] [Article Influence: 12.5] [Reference Citation Analysis]
99 Liu J, Merkle FT, Gandhi AV, Gagnon JA, Woods IG, Chiu CN, Shimogori T, Schier AF, Prober DA. Evolutionarily conserved regulation of hypocretin neuron specification by Lhx9. Development 2015;142:1113-24. [PMID: 25725064 DOI: 10.1242/dev.117424] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
100 Rempe MJ, Best J, Terman D. A mathematical model of the sleep/wake cycle. J Math Biol 2010;60:615-44. [PMID: 19557415 DOI: 10.1007/s00285-009-0276-5] [Cited by in Crossref: 74] [Cited by in F6Publishing: 58] [Article Influence: 5.7] [Reference Citation Analysis]
101 Bodenmann S, Landolt HP. Effects of modafinil on the sleep EEG depend on Val158Met genotype of COMT. Sleep 2010;33:1027-35. [PMID: 20815183 DOI: 10.1093/sleep/33.8.1027] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
102 Nohynek H, Jokinen J, Partinen M, Vaarala O, Kirjavainen T, Sundman J, Himanen SL, Hublin C, Julkunen I, Olsén P, Saarenpää-Heikkilä O, Kilpi T. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One 2012;7:e33536. [PMID: 22470453 DOI: 10.1371/journal.pone.0033536] [Cited by in Crossref: 351] [Cited by in F6Publishing: 295] [Article Influence: 35.1] [Reference Citation Analysis]
103 González JA, Horjales-Araujo E, Fugger L, Broberger C, Burdakov D. Stimulation of orexin/hypocretin neurones by thyrotropin-releasing hormone. J Physiol 2009;587:1179-86. [PMID: 19204048 DOI: 10.1113/jphysiol.2008.167940] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 3.2] [Reference Citation Analysis]
104 Fujimoto T, Rikimaru K, Fukuda K, Sugimoto H, Masuda K, Ohyabu N, Banno Y, Tokunaga N, Kawamoto T, Tomata Y, Kumagai Y, Iida M, Nagano Y, Yoneyama-hirozane M, Shimizu Y, Sasa K, Ishikawa T, Yukitake H, Ito M, Aoyama K, Matsumoto T. Discovery of TAK-925 as a Potent, Selective, and Brain-Penetrant Orexin 2 Receptor Agonist. ACS Med Chem Lett . [DOI: 10.1021/acsmedchemlett.1c00626] [Reference Citation Analysis]
105 Thorpy MJ, Shapiro C, Mayer G, Corser BC, Emsellem H, Plazzi G, Chen D, Carter LP, Wang H, Lu Y, Black J, Dauvilliers Y. A randomized study of solriamfetol for excessive sleepiness in narcolepsy. Ann Neurol 2019;85:359-70. [PMID: 30694576 DOI: 10.1002/ana.25423] [Cited by in Crossref: 69] [Cited by in F6Publishing: 44] [Article Influence: 34.5] [Reference Citation Analysis]
106 Fulcher BD, Phillips AJ, Postnova S, Robinson PA. A physiologically based model of orexinergic stabilization of sleep and wake. PLoS One 2014;9:e91982. [PMID: 24651580 DOI: 10.1371/journal.pone.0091982] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
107 Lopez R, Barateau L, Evangelista E, Chenini S, Robert P, Jaussent I, Dauvilliers Y. Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and Histamine in Narcolepsy. Sleep 2017;40. [PMID: 28364477 DOI: 10.1093/sleep/zsw010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
108 Yang CP, Hsieh ML, Chiang JH, Chang HY, Hsieh VC. Migraine and risk of narcolepsy in children: A nationwide longitudinal study. PLoS One 2017;12:e0189231. [PMID: 29216286 DOI: 10.1371/journal.pone.0189231] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
109 Carlander B, Puech-Cathala AM, Jaussent I, Scholz S, Bayard S, Cochen V, Dauvilliers Y. Low vitamin D in narcolepsy with cataplexy. PLoS One 2011;6:e20433. [PMID: 21633708 DOI: 10.1371/journal.pone.0020433] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
110 Schiappa C, Scarpelli S, D'Atri A, Gorgoni M, De Gennaro L. Narcolepsy and emotional experience: a review of the literature. Behav Brain Funct 2018;14:19. [PMID: 30587203 DOI: 10.1186/s12993-018-0151-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
111 Malhotra A, Shapiro C, Pepin JL, Hedner J, Ahmed M, Foldvary-Schaefer N, Strollo PJ, Mayer G, Sarmiento K, Baladi M, Chandler P, Lee L, Schwab R. Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea. Sleep 2020;43:zsz220. [PMID: 31691827 DOI: 10.1093/sleep/zsz220] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 24.0] [Reference Citation Analysis]
112 Dauvilliers Y, Bisser S, Chapotot F, Vatunga G, Cespuglio R, Josenando T, Buguet A. Hypocretin and human African trypanosomiasis. Sleep 2008;31:348-54. [PMID: 18363311 DOI: 10.1093/sleep/31.3.348] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
113 Tafti M, Hor H, Dauvilliers Y, Lammers GJ, Overeem S, Mayer G, Javidi S, Iranzo A, Santamaria J, Peraita-Adrados R, Vicario JL, Arnulf I, Plazzi G, Bayard S, Poli F, Pizza F, Geisler P, Wierzbicka A, Bassetti CL, Mathis J, Lecendreux M, Donjacour CE, van der Heide A, Heinzer R, Haba-Rubio J, Feketeova E, Högl B, Frauscher B, Benetó A, Khatami R, Cañellas F, Pfister C, Scholz S, Billiard M, Baumann CR, Ercilla G, Verduijn W, Claas FH, Dubois V, Nowak J, Eberhard HP, Pradervand S, Hor CN, Testi M, Tiercy JM, Kutalik Z. DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. Sleep 2014;37:19-25. [PMID: 24381371 DOI: 10.5665/sleep.3300] [Cited by in Crossref: 118] [Cited by in F6Publishing: 103] [Article Influence: 14.8] [Reference Citation Analysis]
114 De la Herrán-Arita AK, García-García F. Current and emerging options for the drug treatment of narcolepsy. Drugs 2013;73:1771-81. [PMID: 24122734 DOI: 10.1007/s40265-013-0127-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
115 Uschakov A, Grivel J, Cvetkovic-Lopes V, Bayer L, Bernheim L, Jones BE, Mühlethaler M, Serafin M. Sleep-deprivation regulates α-2 adrenergic responses of rat hypocretin/orexin neurons. PLoS One 2011;6:e16672. [PMID: 21347440 DOI: 10.1371/journal.pone.0016672] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
116 Montplaisir J, Petit D, Quinn MJ, Ouakki M, Deceuninck G, Desautels A, Mignot E, De Wals P. Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec. PLoS One 2014;9:e108489. [PMID: 25264897 DOI: 10.1371/journal.pone.0108489] [Cited by in Crossref: 64] [Cited by in F6Publishing: 53] [Article Influence: 8.0] [Reference Citation Analysis]
117 Plazzi G, Pizza F, Palaia V, Franceschini C, Poli F, Moghadam KK, Cortelli P, Nobili L, Bruni O, Dauvilliers Y, Lin L, Edwards MJ, Mignot E, Bhatia KP. Complex movement disorders at disease onset in childhood narcolepsy with cataplexy. Brain 2011;134:3477-89. [PMID: 21930661 DOI: 10.1093/brain/awr244] [Cited by in Crossref: 103] [Cited by in F6Publishing: 90] [Article Influence: 9.4] [Reference Citation Analysis]
118 Al-Kuraishy HM, Abdulhadi MH, Hussien NR, Al-Niemi MS, Rasheed HA, Al-Gareeb AI. Involvement of orexinergic system in psychiatric and neurodegenerative disorders: A scoping review. Brain Circ 2020;6:70-80. [PMID: 33033776 DOI: 10.4103/bc.bc_42_19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
119 Yeh JY, Shyu YC, Lee SY, Yuan SS, Yang CJ, Yang KC, Lee TL, Sun CC, Wang LJ. Comorbidity of Narcolepsy and Psychotic Disorders: A Nationwide Population-Based Study in Taiwan. Front Psychiatry 2020;11:205. [PMID: 32269533 DOI: 10.3389/fpsyt.2020.00205] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
120 Bayard S, Abril B, Yu H, Scholz S, Carlander B, Dauvilliers Y. Decision making in narcolepsy with cataplexy. Sleep 2011;34:99-104. [PMID: 21203380 DOI: 10.1093/sleep/34.1.99] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
121 Dauvilliers Y. Altered sleep-related blood pressure profile in hypocretin-deficient narcoleptic patients. Sleep 2012;35:453-4. [PMID: 22467981 DOI: 10.5665/sleep.1720] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
122 Thakkar MM. Histamine in the regulation of wakefulness. Sleep Med Rev 2011;15:65-74. [PMID: 20851648 DOI: 10.1016/j.smrv.2010.06.004] [Cited by in Crossref: 111] [Cited by in F6Publishing: 102] [Article Influence: 9.3] [Reference Citation Analysis]
123 Shan L, Dauvilliers Y, Siegel JM. Interactions of the histamine and hypocretin systems in CNS disorders. Nat Rev Neurol 2015;11:401-13. [PMID: 26100750 DOI: 10.1038/nrneurol.2015.99] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 8.0] [Reference Citation Analysis]
124 Torontali ZA, Fraigne JJ, Sanghera P, Horner R, Peever J. The Sublaterodorsal Tegmental Nucleus Functions to Couple Brain State and Motor Activity during REM Sleep and Wakefulness. Curr Biol 2019;29:3803-3813.e5. [PMID: 31679942 DOI: 10.1016/j.cub.2019.09.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
125 Hartmann FJ, Bernard-Valnet R, Quériault C, Mrdjen D, Weber LM, Galli E, Krieg C, Robinson MD, Nguyen XH, Dauvilliers Y, Liblau RS, Becher B. High-dimensional single-cell analysis reveals the immune signature of narcolepsy. J Exp Med 2016;213:2621-33. [PMID: 27821550 DOI: 10.1084/jem.20160897] [Cited by in Crossref: 68] [Cited by in F6Publishing: 58] [Article Influence: 11.3] [Reference Citation Analysis]
126 Ton TG, Longstreth WT Jr, Koepsell T. Active and passive smoking and risk of narcolepsy in people with HLA DQB1*0602: a population-based case-control study. Neuroepidemiology 2009;32:114-21. [PMID: 19039244 DOI: 10.1159/000177037] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
127 Wändell P, Fredrikson S, Carlsson AC, Li X, Sundquist J, Sundquist K. Narcolepsy among first- and second-generation immigrants in Sweden: A study of the total population. Acta Neurol Scand 2022. [PMID: 35543223 DOI: 10.1111/ane.13633] [Reference Citation Analysis]
128 Ramberger M, Högl B, Stefani A, Mitterling T, Reindl M, Lutterotti A. CD4+ T-Cell Reactivity to Orexin/Hypocretin in Patients With Narcolepsy Type 1. Sleep 2017;40. [PMID: 28364420 DOI: 10.1093/sleep/zsw070] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
129 Syed YY. Pitolisant: First Global Approval. Drugs 2016;76:1313-8. [PMID: 27438291 DOI: 10.1007/s40265-016-0620-1] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 11.8] [Reference Citation Analysis]
130 Partinen M, Saarenpää-Heikkilä O, Ilveskoski I, Hublin C, Linna M, Olsén P, Nokelainen P, Alén R, Wallden T, Espo M, Rusanen H, Olme J, Sätilä H, Arikka H, Kaipainen P, Julkunen I, Kirjavainen T. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One 2012;7:e33723. [PMID: 22470463 DOI: 10.1371/journal.pone.0033723] [Cited by in Crossref: 295] [Cited by in F6Publishing: 232] [Article Influence: 29.5] [Reference Citation Analysis]
131 Song J, Kim T, Kim SM, Um YH, Jeong J, Seo H, Oh JH, Hong SC. Nocturnal Sleep Onset Rapid Eye Movement Sleep Periods as a Predictor of the Severity of Narcolepsy in Korea. Sleep Med Res 2020;11:19-24. [DOI: 10.17241/smr.2019.00444] [Reference Citation Analysis]
132 Thorpy MJ. Furthering the understanding of the pathophysiology of narcolepsy. Curr Neurol Neurosci Rep 2011;11:127-30. [PMID: 21125429 DOI: 10.1007/s11910-010-0165-8] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
133 Lecendreux M, Poli F, Oudiette D, Benazzouz F, Donjacour CE, Franceschini C, Finotti E, Pizza F, Bruni O, Plazzi G. Tolerance and efficacy of sodium oxybate in childhood narcolepsy with cataplexy: a retrospective study. Sleep 2012;35:709-11. [PMID: 22547897 DOI: 10.5665/sleep.1836] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 4.3] [Reference Citation Analysis]
134 Longstreth WT Jr, Ton TG, Koepsell T, Gersuk VH, Hendrickson A, Velde S. Prevalence of narcolepsy in King County, Washington, USA. Sleep Med 2009;10:422-6. [PMID: 19013100 DOI: 10.1016/j.sleep.2008.05.009] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 3.9] [Reference Citation Analysis]
135 Pizza F, Vandi S, Iloti M, Franceschini C, Liguori R, Mignot E, Plazzi G. Nocturnal Sleep Dynamics Identify Narcolepsy Type 1. Sleep 2015;38:1277-84. [PMID: 25845690 DOI: 10.5665/sleep.4908] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 7.1] [Reference Citation Analysis]
136 Tzeng NS, Hsing SC, Chung CH, Chang HA, Kao YC, Mao WC, Yang CCH, Kuo TBJ, Chen TY, Chien WC. The Risk of Hospitalization for Motor Vehicle Accident Injury in Narcolepsy and the Benefits of Stimulant Use: A Nationwide Cohort Study in Taiwan. J Clin Sleep Med 2019;15:881-9. [PMID: 31138389 DOI: 10.5664/jcsm.7842] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
137 Vernet C, Arnulf I. Narcolepsy with long sleep time: a specific entity? Sleep 2009;32:1229-35. [PMID: 19750928 DOI: 10.1093/sleep/32.9.1229] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
138 Fraigne JJ, Torontali ZA, Snow MB, Peever JH. REM Sleep at its Core - Circuits, Neurotransmitters, and Pathophysiology. Front Neurol 2015;6:123. [PMID: 26074874 DOI: 10.3389/fneur.2015.00123] [Cited by in Crossref: 67] [Cited by in F6Publishing: 57] [Article Influence: 9.6] [Reference Citation Analysis]
139 Martin T, Dauvilliers Y, Koumar OC, Bouet V, Freret T, Besnard S, Dauphin F, Bessot N. Dual orexin receptor antagonist induces changes in core body temperature in rats after exercise. Sci Rep 2019;9:18432. [PMID: 31804545 DOI: 10.1038/s41598-019-54826-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
140 Duchêne A, Perier M, Zhao Y, Liu X, Thomasson J, Chauveau F, Piérard C, Lagarde D, Picoli C, Jeanson T, Mouthon F, Dauvilliers Y, Giaume C, Lin JS, Charvériat M. Impact of Astroglial Connexins on Modafinil Pharmacological Properties. Sleep 2016;39:1283-92. [PMID: 27091533 DOI: 10.5665/sleep.5854] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
141 Al Suwayri SM, BaHammam AS. The "Known Unknowns" of Kleine-Levin Syndrome: A Review and Future Prospects. Sleep Med Clin 2017;12:345-58. [PMID: 28778233 DOI: 10.1016/j.jsmc.2017.03.012] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
142 Nixon JP, Mavanji V, Butterick TA, Billington CJ, Kotz CM, Teske JA. Sleep disorders, obesity, and aging: the role of orexin. Ageing Res Rev 2015;20:63-73. [PMID: 25462194 DOI: 10.1016/j.arr.2014.11.001] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 7.6] [Reference Citation Analysis]
143 Barateau L, Lopez R, Dauvilliers Y. Treatment Options for Narcolepsy. CNS Drugs 2016;30:369-79. [PMID: 27155860 DOI: 10.1007/s40263-016-0337-4] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 11.6] [Reference Citation Analysis]
144 Meskill GJ, Kallweit U, Zarycranski D, Caussé C, Finance O, Ligneau X, Davis CW. Pitolisant for the treatment of cataplexy in adults with narcolepsy. Expert Opinion on Orphan Drugs. [DOI: 10.1080/21678707.2021.2022472] [Reference Citation Analysis]
145 Bayard S, Croisier Langenier M, Cochen De Cock V, Scholz S, Dauvilliers Y. Executive control of attention in narcolepsy. PLoS One 2012;7:e33525. [PMID: 22558075 DOI: 10.1371/journal.pone.0033525] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
146 Almeneessier AS, Alballa NS, Alsalman BH, Aleissi S, Olaish AH, BaHammam AS. A 10-Year Longitudinal Observational Study Of Cataplexy In A Cohort Of Narcolepsy Type 1 Patients. Nat Sci Sleep 2019;11:231-9. [PMID: 31695532 DOI: 10.2147/NSS.S229105] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
147 Lecendreux M, Lavault S, Lopez R, Inocente CO, Konofal E, Cortese S, Franco P, Arnulf I, Dauvilliers Y. Attention-Deficit/Hyperactivity Disorder (ADHD) Symptoms in Pediatric Narcolepsy: A Cross-Sectional Study. Sleep 2015;38:1285-95. [PMID: 26118560 DOI: 10.5665/sleep.4910] [Cited by in Crossref: 73] [Cited by in F6Publishing: 62] [Article Influence: 10.4] [Reference Citation Analysis]
148 van der Heide A, Verduijn W, Haasnoot GW, Drabbels JJ, Lammers GJ, Claas FH. HLA dosage effect in narcolepsy with cataplexy. Immunogenetics 2015;67:1-6. [PMID: 25277311 DOI: 10.1007/s00251-014-0808-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
149 Singh AK, Mahlios J, Mignot E. Genetic association, seasonal infections and autoimmune basis of narcolepsy. J Autoimmun 2013;43:26-31. [PMID: 23497937 DOI: 10.1016/j.jaut.2013.02.003] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 7.3] [Reference Citation Analysis]
150 Peter-derex L. Patologie del sonno. EMC - Neurologia 2019;19:1-17. [DOI: 10.1016/s1634-7072(19)42492-6] [Reference Citation Analysis]
151 Lecomte A, Barateau L, Pereira P, Paulin L, Auvinen P, Scheperjans F, Dauvilliers Y. Gut microbiota composition is associated with narcolepsy type 1. Neurol Neuroimmunol Neuroinflamm 2020;7:e896. [PMID: 33037102 DOI: 10.1212/NXI.0000000000000896] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
152 Vellieux G, Frija-Masson J, Rouvel-Tallec A, Drouot X, d'Ortho MP. Narcolepsy Type 1: A Remitting Disease? An Unusual Case Report. Nat Sci Sleep 2021;13:1669-73. [PMID: 34594143 DOI: 10.2147/NSS.S311283] [Reference Citation Analysis]
153 Sansa G, Gavaldà A, Gaig C, Monreal J, Ercilla G, Casamitjana R, Ribera G, Iranzo A, Santamaria J. Exploring the presence of narcolepsy in patients with schizophrenia. BMC Psychiatry 2016;16:177. [PMID: 27245445 DOI: 10.1186/s12888-016-0859-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
154 Braley TJ, Chervin RD. A practical approach to the diagnosis and management of sleep disorders in patients with multiple sclerosis. Ther Adv Neurol Disord 2015;8:294-310. [PMID: 26600873 DOI: 10.1177/1756285615605698] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
155 Whitaker JA, Ovsyannikova IG, Poland GA. Adversomics: a new paradigm for vaccine safety and design. Expert Rev Vaccines 2015;14:935-47. [PMID: 25937189 DOI: 10.1586/14760584.2015.1038249] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
156 Canellas F, Lin L, Julià MR, Clemente A, Vives-Bauza C, Ollila HM, Hong SC, Arboleya SM, Einen MA, Faraco J, Fernandez-Vina M, Mignot E. Dual cases of type 1 narcolepsy with schizophrenia and other psychotic disorders. J Clin Sleep Med 2014;10:1011-8. [PMID: 25142772 DOI: 10.5664/jcsm.4040] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
157 Vuorela A, Freitag TL, Leskinen K, Pessa H, Härkönen T, Stracenski I, Kirjavainen T, Olsen P, Saarenpää-Heikkilä O, Ilonen J, Knip M, Vaheri A, Partinen M, Saavalainen P, Meri S, Vaarala O. Enhanced influenza A H1N1 T cell epitope recognition and cross-reactivity to protein-O-mannosyltransferase 1 in Pandemrix-associated narcolepsy type 1. Nat Commun 2021;12:2283. [PMID: 33863907 DOI: 10.1038/s41467-021-22637-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
158 Chin WC, Liu FY, Huang YS, Hsiao IT, Wang CH, Chen YC. Different positron emission tomography findings in schizophrenia and narcolepsy type 1 in adolescents and young adults: a preliminary study. J Clin Sleep Med 2021;17:739-48. [PMID: 33226331 DOI: 10.5664/jcsm.9032] [Reference Citation Analysis]
159 Akpa B, Lee K. Update on Novel Medications to Treat Narcolepsy. Curr Sleep Medicine Rep 2020;6:189-97. [DOI: 10.1007/s40675-020-00178-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
160 Panda S. Status cataplecticus as initial presentation of late onset narcolepsy. J Clin Sleep Med 2014;10:207-9. [PMID: 24533005 DOI: 10.5664/jcsm.3456] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
161 Dauvilliers YA, Lehmann S, Jaussent I, Gabelle A. Hypocretin and brain β-amyloid peptide interactions in cognitive disorders and narcolepsy. Front Aging Neurosci 2014;6:119. [PMID: 24966833 DOI: 10.3389/fnagi.2014.00119] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
162 Meletti S, Vaudano AE, Pizza F, Ruggieri A, Vandi S, Teggi A, Franceschini C, Benuzzi F, Nichelli PF, Plazzi G. The Brain Correlates of Laugh and Cataplexy in Childhood Narcolepsy. J Neurosci 2015;35:11583-94. [PMID: 26290235 DOI: 10.1523/JNEUROSCI.0840-15.2015] [Cited by in Crossref: 41] [Cited by in F6Publishing: 15] [Article Influence: 5.9] [Reference Citation Analysis]
163 Alomar M, Almeneessier AS, Olaish AH, Alshiban A, Alomar A, BaHammam AS. Immune-mediated comorbidities in Saudi patients with narcolepsy. Nat Sci Sleep 2019;11:35-43. [PMID: 31118849 DOI: 10.2147/NSS.S195650] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
164 Jardri R, Bartels-Velthuis AA, Debbané M, Jenner JA, Kelleher I, Dauvilliers Y, Plazzi G, Demeulemeester M, David CN, Rapoport J, Dobbelaere D, Escher S, Fernyhough C. From phenomenology to neurophysiological understanding of hallucinations in children and adolescents. Schizophr Bull 2014;40 Suppl 4:S221-32. [PMID: 24936083 DOI: 10.1093/schbul/sbu029] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 7.9] [Reference Citation Analysis]
165 Schöne C, Burdakov D. Orexin/Hypocretin and Organizing Principles for a Diversity of Wake-Promoting Neurons in the Brain. Curr Top Behav Neurosci 2017;33:51-74. [PMID: 27830577 DOI: 10.1007/7854_2016_45] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
166 Oudiette D, Dodet P, Ledard N, Artru E, Rachidi I, Similowski T, Arnulf I. REM sleep respiratory behaviours mental content in narcoleptic lucid dreamers. Sci Rep 2018;8:2636. [PMID: 29422603 DOI: 10.1038/s41598-018-21067-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
167 Chen TY, Su VY, Lee CH, Chung CH, Tsai CK, Peng CK, Lai HC, Chien WC, Tzeng NS. The Association Between Asthma and Narcolepsy: A Nationwide Case-Control Study in Taiwan. Nat Sci Sleep 2021;13:1631-40. [PMID: 34584477 DOI: 10.2147/NSS.S317746] [Reference Citation Analysis]
168 Bettinotti MP, Ferriola D, Duke JL, Mosbruger TL, Tairis N, Jennings L, Kalman LV, Monos D. Characterization of 108 Genomic DNA Reference Materials for 11 Human Leukocyte Antigen Loci: A GeT-RM Collaborative Project. J Mol Diagn 2018;20:703-15. [PMID: 29959025 DOI: 10.1016/j.jmoldx.2018.05.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
169 Posar A, Visconti P, Blunda V, Pizza F, Plazzi G. Autism Spectrum Disorder and Narcolepsy: A Possible Connection That Deserves to Be Investigated. Front Psychiatry 2020;11:265. [PMID: 32322223 DOI: 10.3389/fpsyt.2020.00265] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
170 Schokman A, Glozier N, Aji M, Sun Bin Y, Kairaitis K, Cheung JMY. How patient centric is health policy development? The case of the Parliamentary Inquiry into Sleep Health Awareness in Australia. Aust Health Rev 2022;46:233-43. [PMID: 35380105 DOI: 10.1071/AH21156] [Reference Citation Analysis]
171 Ellenbogen JM, Pace-Schott EF. Drug-induced sleep: theoretical and practical considerations. Pflugers Arch 2012;463:177-86. [PMID: 21953011 DOI: 10.1007/s00424-011-1033-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
172 Mayer G. [Narcolepsy]. Nervenarzt 2014;85:26, 28-34. [PMID: 24408296 DOI: 10.1007/s00115-013-3889-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
173 Chen L, Brown RE, McKenna JT, McCarley RW. Animal models of narcolepsy. CNS Neurol Disord Drug Targets 2009;8:296-308. [PMID: 19689311 DOI: 10.2174/187152709788921717] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
174 Gool JK, van der Werf YD, Lammers GJ, Fronczek R. The Sustained Attention to Response Task Shows Lower Cingulo-Opercular and Frontoparietal Activity in People with Narcolepsy Type 1: An fMRI Study on the Neural Regulation of Attention. Brain Sci 2020;10:E419. [PMID: 32630358 DOI: 10.3390/brainsci10070419] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
175 Kosse C, Gonzalez A, Burdakov D. Predictive models of glucose control: roles for glucose-sensing neurones. Acta Physiol (Oxf) 2015;213:7-18. [PMID: 25131833 DOI: 10.1111/apha.12360] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
176 Diniz Behn CG, Kopell N, Brown EN, Mochizuki T, Scammell TE. Delayed orexin signaling consolidates wakefulness and sleep: physiology and modeling. J Neurophysiol 2008;99:3090-103. [PMID: 18417630 DOI: 10.1152/jn.01243.2007] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
177 Quaedackers L, De Wit J, Pillen S, Van Gilst M, Batalas N, Lammers GJ, Markopoulos P, Overeem S. A Mobile App for Longterm Monitoring of Narcolepsy Symptoms: Design, Development, and Evaluation. JMIR Mhealth Uhealth 2020;8:e14939. [PMID: 31909723 DOI: 10.2196/14939] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
178 Kosse C, Burdakov D. A unifying computational framework for stability and flexibility of arousal. Front Syst Neurosci 2014;8:192. [PMID: 25368557 DOI: 10.3389/fnsys.2014.00192] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
179 Barateau L, Jaussent I, Lopez R, Boutrel B, Leu-Semenescu S, Arnulf I, Dauvilliers Y. Smoking, Alcohol, Drug Use, Abuse and Dependence in Narcolepsy and Idiopathic Hypersomnia: A Case-Control Study. Sleep 2016;39:573-80. [PMID: 26564129 DOI: 10.5665/sleep.5530] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
180 Deloumeau A, Bayard S, Coquerel Q, Déchelotte P, Bole-Feysot C, Carlander B, Cochen De Cock V, Fetissov SO, Dauvilliers Y. Increased immune complexes of hypocretin autoantibodies in narcolepsy. PLoS One 2010;5:e13320. [PMID: 20967199 DOI: 10.1371/journal.pone.0013320] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
181 van Holst RJ, Janssen LK, van Mierlo P, Lammers GJ, Cools R, Overeem S, Aarts E. Enhanced food-related responses in the ventral medial prefrontal cortex in narcolepsy type 1. Sci Rep 2018;8:16391. [PMID: 30401926 DOI: 10.1038/s41598-018-34647-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
182 Carlander B, Vincent T, Le Floch A, Pageot N, Camu W, Dauvilliers Y. Hypocretinergic dysfunction in neuromyelitis optica with coma-like episodes. BMJ Case Rep 2009;2009:bcr08. [PMID: 21686670 DOI: 10.1136/bcr.08.2008.0709] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
183 Alshaikh MK, Tricco AC, Tashkandi M, Mamdani M, Straus SE, BaHammam AS. Sodium oxybate for narcolepsy with cataplexy: systematic review and meta-analysis. J Clin Sleep Med 2012;8:451-8. [PMID: 22893778 DOI: 10.5664/jcsm.2048] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 4.5] [Reference Citation Analysis]
184 Dunne L, Patel P, Maschauer EL, Morrison I, Riha RL. Misdiagnosis of narcolepsy. Sleep Breath 2016;20:1277-84. [PMID: 27339629 DOI: 10.1007/s11325-016-1365-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
185 Pillen S, Pizza F, Dhondt K, Scammell TE, Overeem S. Cataplexy and Its Mimics: Clinical Recognition and Management. Curr Treat Options Neurol 2017;19:23. [PMID: 28478511 DOI: 10.1007/s11940-017-0459-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
186 Filardi M, Pizza F, Tonetti L, Antelmi E, Natale V, Plazzi G. Attention impairments and ADHD symptoms in adult narcoleptic patients with and without hypocretin deficiency. PLoS One 2017;12:e0182085. [PMID: 28763482 DOI: 10.1371/journal.pone.0182085] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
187 Partinen M. All children with narcolepsy type 1 should be encouraged to sleep regular naps during daytime. Sleep Med 2016;24:145-6. [PMID: 27810180 DOI: 10.1016/j.sleep.2016.10.003] [Reference Citation Analysis]